Suchergebnisse - "2494G1JF75"

PubPharm (985)

921

Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients

enthalten in: Journal of virology | 2001

von Kempf, D. | Isaacson, J. | King, M. | +7

922

New drug approvals in 2000

enthalten in: General dentistry | 2001

von Wynn, R.

923

Accumulation of lopinavir resistance-associated mutations over 3 years follow-up of patients on highly active antiretroviral therapy : implication in salvage therapy

enthalten in: AIDS (London, England) | 2001

von Tsuchiya, K. | Matsuoka, S. | Hachiya, A. | +7

924

Antiretroviral approved for use in infants

enthalten in: American family physician | 2001

925

Synthesis and antiviral activities of the major metabolites of the HIV protease inhibitor ABT-378 (Lopinavir)

enthalten in: Bioorganic & medicinal chemistry letters | 2001

von Sham, H. | Betebenner, D. | Herrin, T. | +7

ErratumIn: Bioorg Med Chem Lett. 2004 May 17;14(10):2695

926

Resistant to everything

enthalten in: AIDS clinical care | 2001

von Mazzullo, J. | Piliero, P.

927

The importance of sequencing in treatment options

enthalten in: Positively aware : the monthly journal of the Test Positive Aware Network | 2001

von Berger, D.

928

Inflammatory oedema of the legs : a new side-effect of lopinavir

enthalten in: AIDS (London, England) | 2001

von Lascaux, A. | Lesprit, P. | Bertocchi, M. | +1

929

No resistance even after 1 year. New drug combination against HIV

enthalten in: MMW Fortschritte der Medizin | 2001

930

An option even for patients with multiple pretreatment

enthalten in: MMW Fortschritte der Medizin | 2001